Related Experiment Videos

Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines

Domenico De Mattia1, Giovanni Carlo Del Vecchio, Giovanna Russo

  • 1Dipartimento di Biomedicina dell'Eta Evolutiva, Universita di Bari, Azienda Ospedaliera Policlinico, Piazza G. Cesare 11, IT-0124 Bari, Italy. demattia@bioetaev.uniba.it

Acta Haematologica
|December 24, 2009
PubMed

Insights

Guidelines for chronic childhood idiopathic thrombocytopenic purpura (ITP) emphasize that most children do not need treatment unless bleeding is severe. Management decisions consider various factors beyond platelet count, offering tailored recommendations for different scenarios.

Area of Science:

  • Pediatric Hematology
  • Clinical Guidelines
  • Immune Thrombocytopenia

Background:

  • Chronic childhood immune thrombocytopenic purpura (ITP) management differs from acute forms.
  • The Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) recognized the need for specific guidelines for chronic pediatric ITP.

Purpose of the Study:

  • To develop consensus guidelines for managing chronic childhood ITP.
  • To provide shared, evidence-based information for healthcare professionals, parents, and patients.

Main Methods:

  • A preliminary evidence-based document was drafted by AIEOP pediatric hematologists.
  • The document was discussed, modified, and approved during a Consensus Conference.
  • The process followed procedures validated by the AIEOP Board.

Main Results:

  • Guidelines highlight the importance of reevaluating etiological hypotheses for thrombocytopenia.
  • Most children with chronic ITP do not require treatment, particularly if bleeding is minimal.
  • Treatment decisions are multifactorial, considering clinical condition beyond platelet count.

Conclusions:

  • Treatment options are suggested based on therapeutic scenarios and clinical factors.
  • Recommendations cover surgical support, managing hemorrhagic conditions, daily activities, sports, vaccines, and medications.
  • The guidelines also address the discussion of experimental treatments for chronic ITP.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...